Bone regeneration with BMP-2 delivered from keratose scaffolds

Biomaterials

Volumn 34, Issue 6, 2013, Pages 1644-1656

  de Guzman, Roche C ^a   Saul, Justin M ^b   Ellenburg, Mary D ^a   Merrill, Michelle R ^a   Coan, Heather B ^a   Smith, Thomas L ^a   Van Dyke, Mark E ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b MIAMI UNIVERSITY   (United States)

Author keywords

BMP 2 delivery; Bone regeneration; Critical size defect; Keratin; Keratose biomaterial; Tissue engineering

Indexed keywords

ADIPOSE TISSUE; BMP-2 DELIVERY; BONE REGENERATION; BONE REPAIR; CARRIER SYSTEMS; CORTICAL BONE; CROSSLINKED; FTIR-ATR SPECTROSCOPY; HETEROTOPIC OSSIFICATION; IN-VITRO ANALYSIS; KERATIN; MINERAL CONTENT; NEGATIVE CONTROL; OSTEOGENESIS; SCAFFOLD DEGRADATION; STRESS VALUES; TIME POINTS;

BIOMATERIALS; BIOMECHANICS; COLLAGEN; DEFECTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; TISSUE; TISSUE ENGINEERING;

BONE;

KERATIN; KERATOSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DEVELOPMENT; BONE MINERAL; BONE REGENERATION; CALLUS; CONTROLLED STUDY; CORTICAL BONE; HUMAN; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR STRESS; TISSUE REGENERATION;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; RATS; REGENERATION; SPECTROPHOTOMETRY, INFRARED; TISSUE SCAFFOLDS;

RATTUS;

EID: 84870796456     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.002     Document Type: Article

References (43)

1. Keating J.F., Simpson A.H., Robinson C.M. The management of fractures with bone loss. J Bone Jt Surg Brs 2005, 87:142-150.
2. DeCoster T.A., Gehlert R.J., Mikola E.A., Pirela-Cruz M.A. Management of posttraumatic segmental bone defects. J Am Acad Orthop Surg 2004, 12:28-38.
3. Fuchs B., Ossendorf C., Leerapun T., Sim F.H. Intercalary segmental reconstruction after bone tumor resection. Eur J Surg Oncol 2008, 34:1271-1276.
4. McKee M.D. Management of segmental bony defects: the role of osteoconductive orthobiologics. J Am Acad Orthop Surg 2006, 14:S163-S167.
5. Lissenberg-Thunnissen S.N., de Gorter D.J., Sier C.F., Schipper I.B. Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 2011, 35:1271-1280.
6. Uludag H., Friess W., Williams D., Porter T., Timony G., D'Augusta D., et al. rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics. Ann N Y Acad Sci 1999, 875:369-378.
7. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Jt Surg Am 2002, 84-A:2123-2134.
8. Guo J., Li C., Zhang Q., Wu G., Deacon S.A., Chen J., et al. Secondary bone grafting for alveolar cleft in children with cleft lip or cleft lip and palate. Cochrane Database Syst Rev 2011, CD008050.
9. Schwartz N.D., Hicks B.M. Segmental bone defects treated using recombinant human bone morphogenetic protein. J Orthop 2006, 3:e2.
10. Jones A.L., Bucholz R.W., Bosse M.J., Mirza S.K., Lyon T.R., Webb L.X., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Jt Surg Am 2006, 88:1431-1441.
11. Ghodadra N., Singh K. Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biologics 2008, 2:345-354.
12. Woo E.J. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 2012, 70:765-767.
13. Carreon L.Y., Glassman S.D., Brock D.C., Dimar J.R., Puno R.M., Campbell M.J. Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery. Spine (Phila Pa 1976) 2008, 33:391-393.
14. Wong D.A., Kumar A., Jatana S., Ghiselli G., Wong K. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008, 8:1011-1018.
15. Balseiro S., Nottmeier E.W. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases. Spine J 2010, 10:e6-e10.
16. McClellan J.W., Mulconrey D.S., Forbes R.J., Fullmer N. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006, 19:483-486.
17. Joseph V., Rampersaud Y.R. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis. Spine (Phila Pa 1976) 2007, 32:2885-2890.
18. Boraiah S., Paul O., Hawkes D., Wickham M., Lorich D.G. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res 2009, 467:3257-3262.
19. Haidar Z.S., Hamdy R.C., Tabrizian M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: delivery systems for BMPs in orthopaedic and craniofacial tissue engineering. Biotechnol Lett 2009, 31:1825-1835.
20. Geiger M., Li R.H., Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003, 55:1613-1629.
21. de Guzman R.C., Merrill M.R., Richter J.R., Hamzi R.I., Greengauz-Roberts O.K., Van Dyke M.E. Mechanical and biological properties of keratose biomaterials. Biomaterials 2011, 32:8205-8217.
22. Kirfel J., Magin T.M., Reichelt J. Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 2003, 60:56-71.
23. Sierpinski P., Garrett J., Ma J., Apel P., Klorig D., Smith T., et al. The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves. Biomaterials 2008, 29:118-128.
24. Thilagar S., Jothi N.A., Omar A.R., Kamaruddin M.Y., Ganabadi S. Effect of keratin-gelatin and bFGF-gelatin composite film as a sandwich layer for full-thickness skin mesh graft in experimental dogs. J Biomed Mater Res B Appl Biomater 2009, 88:12-16.
25. Dias G.J., Mahoney P., Swain M., Kelly R.J., Smith R.A., Ali M.A. Keratin-hydroxyapatite composites: biocompatibility, osseointegration, and physical properties in an ovine model. J Biomed Mater Res A 2010, 95:1084-1095.
26. Mann F.A., Payne J.T. Bone healing. Semin Vet Med Surg 1989, 4:312-321.
27. Alexander P., Earland C. Structure of wool fibres; isolation of an alpha and beta-protein in wool. Nature 1950, 166:396-397.
28. Oest M.E., Dupont K.M., Kong H.J., Mooney D.J., Guldberg R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 2007, 25:941-950.
29. Miller-Chou B.A., Koenig J.L. A review of polymer dissolution. Prog Polym Sci 2003, 28:1223-1270.
30. Ferretti J.L., Gaffuri O., Capozza R., Cointry G., Bozzini C., Olivera M., et al. Dexamethasone effects on mechanical, geometric and densitometric properties of rat femur diaphyses as described by peripheral quantitative computerized tomography and bending tests. Bone 1995, 16:119-124.
31. Suntornsaratoon P., Wongdee K., Krishnamra N., Charoenphandhu N. Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats. J Physiol Sci 2010, 60:1-8.
32. Figueiredo M.M., Gamelas J.A.F., Martins A.G. Characterization of bone and bone-based graft materials using FTIR spectroscopy. Infrared spectroscopy - life and biomedical sciences 2012, 315-338. InTech, Rijeka, Croatia. T. Theophanides (Ed.).
33. Gazi E., Dwyer J., Lockyer N.P., Gardner P., Shanks J.H., Roulson J., et al. Biomolecular profiling of metastatic prostate cancer cells in bone marrow tissue using FTIR microspectroscopy: a pilot study. Anal Bioanal Chem 2007, 387:1621-1631.
34. Slosarczyk A., Paszkiewicz Z., Paluszkiewicz C. FTIR and XRD evaluation of carbonated hydroxyapatite powders synthesized by wet methods. J Mol Struct 2005, 744:657-661.
35. Alexander P., Hudson R.F., Fox M. The reaction of oxidizing agents with wool. 1. the division of cystine into two fractions of widely differing reactivities. Biochem J 1950, 46:27-32.
36. Saul J.M., Ellenburg M.D., de Guzman R.C., Van Dyke M.E. Keratin hydrogels support the sustained release of bioactive ciprofloxacin. J Biomed Mater Res A 2011, 98:544-553.
37. Tachibana A., Nishikawa Y., Nishino M., Kaneko S., Tanabe T., Yamauchi K. Modified keratin sponge: binding of bone morphogenetic protein-2 and osteoblast differentiation. J Biosci Bioeng 2006, 102:425-429.
38. Ulstrup A.K. Biomechanical concepts of fracture healing in weight-bearing long bones. Acta Orthop Belg 2008, 74:291-302.
39. Bastian O., Pillay J., Alblas J., Leenen L., Koenderman L., Blokhuis T. Systemic inflammation and fracture healing. J Leukoc Biol 2011, 89:669-673.
40. Kwong F.N., Harris M.B. Recent developments in the biology of fracture repair. J Am Acad Orthop Surg 2008, 16:619-625.
41. Sando L., Kim M., Colgrave M.L., Ramshaw J.A., Werkmeister J.A., Elvin C.M. Photochemical crosslinking of soluble wool keratins produces a mechanically stable biomaterial that supports cell adhesion and proliferation. J Biomed Mater Res A 2010, 95:901-911.
42. Devescovi V., Leonardi E., Ciapetti G., Cenni E. Growth factors in bone repair. Chir Organi Mov 2008, 92:161-168.
43. Fiedler J., Roderer G., Gunther K.P., Brenner R.E. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002, 87:305-312.